T
The420Guy
Guest
BERLIN - Chemicals found in cannabis can significantly reduce the symptoms
of Tourette's syndrome, study findings suggest.
Tourette's syndrome is a neurological condition characterized by
uncontrollable facial grimaces, tics, and involuntary grunts, snorts and
shouts.
Dr. Kirsten Mueller-Vahl of the Hanover Medical College in Germany led a
team that investigated the effects of chemicals called cannabinols in 12
adult Tourette's patients.
In the study, each patient was given a single oral dose of d9-THC--the most
psychoactive chemical in cannabis--calculated based on their body weight,
sex, age and prior use of marijuana, or a dose of inactive placebo.
Symptoms were measured after the first treatment, and compared to symptoms
after the same patient was switched to the other pill. Neither the patient
nor the investigator knew whether they were given a placebo or the active
treatment first.
A single dose of the cannabinol produced a significant reduction in
symptoms for several hours compared to placebo, the researchers report in
the April issue of Pharmacopsychiatry.
"The effects were clear," Mueller-Vahl told Reuters Health. "What was also
interesting was that some patients experienced far greater effects than
others. Some had a great effect, some only (a small effect), and a few none
at all. But generally, the level of tic activity was reduced as were the
compulsions, such as to shout, spit or swear."
Mueller-Vahl's team has also recently finished a 6-week long study with 24
patients.
Although the results are not yet published, the researcher said, "The
second study supported what we had gathered from the initial one. Those
taking the THC had significantly less tic behaviour."
Around 50,000 people in Germany alone have Tourette's syndrome, a complex
neurological-psychiatric condition. Its cause remains unknown.
Current treatments are generally limited in effectiveness and often have
considerable side effects. Mueller-Vahl said she wanted to see further
research conducted on the potential medical uses of cannabis-based drugs.
"Marijuana and hashish from cannabis plants have been used as a medicine
for centuries in various cultures," she said.
"In modern cultures, cannabis--because of its abusive use as a recreational
drug and not least because of the long-unknown combination of
chemicals--has until now barely played a role. There are around 80
different active chemicals in the cannabis plant," she noted.
"There is anecdotal evidence to suggest that the consumption of marijuana
clearly and continuously benefits Tourette patients," Mueller-Vahl pointed
out. "There is also a strong suggestion that the plant cannabis is more
effective than synthetic THC, and that patients taking the mixture
experience fewer unpleasant side effects."
She said the results opened up other potential areas of research. "The
results prompt the question of how far the central cannabinoid receptor
system of the brain plays a part in the origins of the condition,"
Mueller-Vahl noted. "The study should encourage further research into the
effects of cannabis as well as some of the individual substances it
contains, with other diseases too."
Pubdate: Tue, 02 Apr 2002
Source: Reuters (Wire)
Copyright: 2002 Reuters Limited
Author: Hannah Cleaver
of Tourette's syndrome, study findings suggest.
Tourette's syndrome is a neurological condition characterized by
uncontrollable facial grimaces, tics, and involuntary grunts, snorts and
shouts.
Dr. Kirsten Mueller-Vahl of the Hanover Medical College in Germany led a
team that investigated the effects of chemicals called cannabinols in 12
adult Tourette's patients.
In the study, each patient was given a single oral dose of d9-THC--the most
psychoactive chemical in cannabis--calculated based on their body weight,
sex, age and prior use of marijuana, or a dose of inactive placebo.
Symptoms were measured after the first treatment, and compared to symptoms
after the same patient was switched to the other pill. Neither the patient
nor the investigator knew whether they were given a placebo or the active
treatment first.
A single dose of the cannabinol produced a significant reduction in
symptoms for several hours compared to placebo, the researchers report in
the April issue of Pharmacopsychiatry.
"The effects were clear," Mueller-Vahl told Reuters Health. "What was also
interesting was that some patients experienced far greater effects than
others. Some had a great effect, some only (a small effect), and a few none
at all. But generally, the level of tic activity was reduced as were the
compulsions, such as to shout, spit or swear."
Mueller-Vahl's team has also recently finished a 6-week long study with 24
patients.
Although the results are not yet published, the researcher said, "The
second study supported what we had gathered from the initial one. Those
taking the THC had significantly less tic behaviour."
Around 50,000 people in Germany alone have Tourette's syndrome, a complex
neurological-psychiatric condition. Its cause remains unknown.
Current treatments are generally limited in effectiveness and often have
considerable side effects. Mueller-Vahl said she wanted to see further
research conducted on the potential medical uses of cannabis-based drugs.
"Marijuana and hashish from cannabis plants have been used as a medicine
for centuries in various cultures," she said.
"In modern cultures, cannabis--because of its abusive use as a recreational
drug and not least because of the long-unknown combination of
chemicals--has until now barely played a role. There are around 80
different active chemicals in the cannabis plant," she noted.
"There is anecdotal evidence to suggest that the consumption of marijuana
clearly and continuously benefits Tourette patients," Mueller-Vahl pointed
out. "There is also a strong suggestion that the plant cannabis is more
effective than synthetic THC, and that patients taking the mixture
experience fewer unpleasant side effects."
She said the results opened up other potential areas of research. "The
results prompt the question of how far the central cannabinoid receptor
system of the brain plays a part in the origins of the condition,"
Mueller-Vahl noted. "The study should encourage further research into the
effects of cannabis as well as some of the individual substances it
contains, with other diseases too."
Pubdate: Tue, 02 Apr 2002
Source: Reuters (Wire)
Copyright: 2002 Reuters Limited
Author: Hannah Cleaver
